RegenMed Systems is a leading brand in the field of regenerative medicine, specializing in the advancement of marrow-derived therapies for cardiovascular disease, orthopedics, and beyond. Their flagship product, MarrowMiner, is a cutting-edge, minimally invasive device designed for the harvest of bone marrow stem cells. Developed by Stanford Biodesign, MarrowMiner is revolutionizing the way stem cells are collected, making the process more efficient and less invasive.

The team behind RegenMed Systems is composed of highly accomplished individuals. Dr. Michael McCullough, the Founder, CEO, and Chairman, has an impressive background as a serial entrepreneur, investor, and healthcare professional.

Meanwhile, Mike Crocker, the Co-Founder and Vice President of Engineering, brings over 20 years of experience in medical device engineering to the table. Diana Saville, the Chief Operating Officer, is a Harvard and Berkeley-trained scientist with a strong track record in healthcare innovation. With a mission to advance regenerative medicine, RegenMed Systems is at the forefront of innovation, bridging the gap between medical technology and patient care.

Their vision is to provide groundbreaking solutions that improve the lives of patients and accelerate the development of regenerative therapies